hengrui glp-1 Kailera says obesity pill succeeds in late-stage trial in China Hengrui Leads Oral GLP-1, Shanghai

A 2021 review in The New England Journal of Medicine confirmed that GLP-1 analogs significantly outperformed placebo and standard weight loss programs

Small studies in lupus patients on GLP-1 therapy have suggested fewer flares and possible protection against progression to kidney disease in lupus nephritis

Foods like whole grains, fruits, and vegetables can contribute to softer stools and alleviate constipation

The real question is whether this space will mature into a legitimate, responsible arm of obesity medicine or be dismissed as a chaotic market of pill mills

The combined 4mg groups lost 17.1%

Ejarque M, Sabadell-Basallote J, Beiroa D, Calvo E, Keiran N, Nuez-Roa C, et al